Related Experiment Videos
Endolysosomal processing of exogenous antigen into major histocompatibility complex class I-binding peptides.
Scandinavian Journal of Immunology
|June 9, 2004
Summary
An alternative endolysosomal pathway processes MHC-I peptides in dendritic cells (DCs). This pathway is functional in immature DCs, independent of the proteasomal complex, and guided by MHC-I chaperone function.
Area of Science:
- Immunology
- Cell Biology
Background:
- A novel endolysosomal pathway for MHC-I peptide processing has been proposed.
- The precise location of peptide processing within antigen-presenting cells remains debated.
Purpose of the Study:
- To investigate the functional role of the endolysosomal pathway in MHC-I peptide processing in dendritic cells.
- To determine whether peptide processing occurs within endolysosomes or the proteasome.
Main Methods:
- Utilized monoclonal antibodies against SIINFEKL/Kb complexes and glycopeptides.
- Employed inhibitors of classical and endolysosomal MHC-I processing pathways.
- Analyzed peptide/MHC-I complex expression on immature dendritic cells (iDCs).
Main Results:
- Alternative MHC-I processing was observed in both wild-type and TAP1(-/-) iDCs.
- Internalized glycopeptides appeared on the cell surface after MHC-I binding.
- Evidence of peptide exchange within Kb molecules was demonstrated.
Conclusions:
- Data support a functional endolysosomal processing pathway in iDCs.
- This pathway is independent of the proteasomal complex.
- MHC-I chaperone function guides the endolysosomal processing pathway.